Skip to content
stoqly
en · USD

Appearance

Language

Currency

Popular

All currencies

Data is in US dollars, converted at the exchange rate of Oct 28, 2026.

Sign in

Howard Horn

Chief Financial Officer, Ultragenyx Pharmaceutical Inc.

Bought, 12 months
$0.0M
Sold, 12 months
$1.2M
Companies
1
Latest trade
Oct 15, 2026

Companies

Ultragenyx Pharmaceutical Inc.Chief Financial Officer −$1.4M

Trades

RARE Sold 7,066 shares at $15.27 $0.1M Oct 15 Form 4
RARE Sold 4,696 shares at $24.92 · planned $0.1M Aug 3 Form 4
RARE Sold 4,698 shares at $33.13 · planned $0.2M Jul 1 Form 4
RARE Sold 4,653 shares at $23.77 · planned $0.1M Jun 1 Form 4
RARE Sold 4,683 shares at $24.90 · planned $0.1M May 1 Form 4
RARE Sold 4,683 shares at $20.97 · planned $0.1M Apr 1 Form 4
RARE Sold 1,635 shares at $22.40 · planned $0.0M Mar 3 Form 4
RARE Sold 8,409 shares at $22.70 · planned $0.2M Mar 2 Form 4
RARE Sold 3,061 shares at $23.56 · planned $0.1M Feb 2 Form 4
RARE Sold 3,150 shares at $22.84 · planned $0.1M Jan 2 Form 4
RARE Sold 3,081 shares at $36.38 · planned $0.1M Dec 10 Form 4
RARE Sold 7,942 shares at $31.51 $0.3M Oct 13 Form 4

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.

↑ ↓ to move · ↵ to open